Patents by Inventor Henk M. Lokhorst

Henk M. Lokhorst has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination therapies for heme malignancies with anti-CD38 antibodies and survivin inhibitors
    Patent number: 10668149
    Abstract: The present invention relates to combination therapies for heme malignancies with anti-CD38 antibodies and survivin inhibitors.
    Type: Grant
    Filed: June 22, 2016
    Date of Patent: June 2, 2020
    Assignee: Janssen Biotech, Inc.
    Inventors: Parul Doshi, Henk M. Lokhorst, Tuna Mutis
  • Combination therapies with anti-CD38 antibodies
    Patent number: 10604580
    Abstract: The present invention relates to combination therapies with anti-CD38 antibodies and all-trans retinoic acid.
    Type: Grant
    Filed: December 21, 2016
    Date of Patent: March 31, 2020
    Assignee: JANSSEN BIOTECH, INC.
    Inventors: Henk M. Lokhorst, Tuna Mutis, Inger S Nijhof, Niels Van de Donk
  • Combination Therapies with Anti-CD38 Antibodies
    Publication number: 20170107295
    Abstract: The present invention relates to combination therapies with anti-CD38 antibodies and all-trans retinoic acid.
    Type: Application
    Filed: December 21, 2016
    Publication date: April 20, 2017
    Inventors: Henk M. Lokhorst, Tuna Mutis, Inger S Nijhof, Niels Van de Donk
  • Combination therapies for heme malignancies with Anti-CD38 antibodies and survivin inhibitors
    Publication number: 20160367663
    Abstract: The present invention relates to combination therapies for heme malignancies with anti-CD38 antibodies and survivin inhibitors.
    Type: Application
    Filed: June 22, 2016
    Publication date: December 22, 2016
    Inventors: Parul Doshi, Henk M. Lokhorst, Tuna Mutis
  • Combination Therapies with Anti-CD38 Antibodies
    Publication number: 20160067205
    Abstract: The present invention relates to combination therapies with anti-CD38 antibodies and all-trans retinoic acid.
    Type: Application
    Filed: September 8, 2015
    Publication date: March 10, 2016
    Inventors: Henk M. Lokhorst, Tuna Mutis, Inger S Nijhof, Niels Van de Donk